Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear?
Beaugerie
Laurent
L
Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine 184 rue du faubourg Saint-Antoine, Paris Cedex 12, France. laurent.beaugerie@sat.aphp.fr
Gerbes
Alexander L
AL
D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D016174:Hepacivirus / Q000502:physiology; D006515:Hepatitis B virus / Q000502:physiology; D019694:Hepatitis B, Chronic / Q000150:complications; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000188:drug therapy*; D014775:Virus Activation / Q000187:drug effects
D007166:Immunosuppressive Agents